对于局部晚期非小细胞肺癌患者无论是否行手术，其主要的治疗模式是行放疗（RT）联合化疗。放射性肺炎是胸部RT最主要的治疗相关的毒性。V20<35%，平均肺剂量（MLD）<20Gy通常被认为是非手术患者行RT的肺剂量容积的上限。在可手术的局部晚期NSCLC患者中，手术可能导致肺组织对放疗的耐受性下降。术后放疗

展位（3m×3m）： 国内企业RMB 7200元/展位。2．室内特装展位（36㎡起租）：国内企业RMB 800元/㎡。境外国际标准展位9...》25000元/版；拱门6000元/个；彩旗150元/面；汽飘（12m×0.75m）3000元/组；墙幅（高12m×宽3m）9000元/幅；室外

北京安贞脑血管病论坛 2011年7月9—10日 中国.北京尊敬的各位同道...效果并得到了同道的认可和好评。在前两届成功办会的基础上，首都医科大学附属北京安贞医院将与中华医学会联合于2011年7月

M.D.Anderson癌症中心消化道肿瘤系高级访问学者。现任解放军八一医院副院长、全军肿瘤中心主任兼国家药物临床试验机构主任。长期从事肿瘤内科临床与科研工作，擅长消化系统...，1999～2000年美国M.D.Anderson癌症中心消化道肿瘤系高级访问学者。现任解放军八一医院副院长、全军肿瘤中心主任兼国家药物临床试验机构主任。长期从事

包括M1-4病情、T3b/T4期病情或术后残存瘤体大于1.5cm3。研究者将术后髓母细胞瘤高风险患儿随机分配至两组，治疗方案分别为，在放疗前进行3个周期顺铂...2013年7月15日在线出版的《临床肿瘤学杂志》(Journal of Clinical Oncology)发表了美国麻省总医院Nancy J. Tarbell

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析（GWAS）为全面系统研究复杂疾病的遗传因素掀开了新的一页，为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因，我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目，吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员，特别是广大研究生了解GWAS的研究原理和方法，学会设计GWAS的研究和分析实验结果，同时在癌症领域分享海内外研究专家们的成功经验，并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加，请有意者及时将回执返回联系邮箱。免注册费（食宿餐饮费用自理）。名额有限，报名从速！时间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆 上海市邯郸路220号，200433
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹 高歌 联系电话： 021-55664495
回执邮箱： GWAS2009@gmail.com
&nbsp;BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives&bull; To better understand the potential applications of GWAS
&bull; To address practical issues in study design, implementation, and data analysis of GWAS
&bull; To promote interaction and collaboration among researchers who are interested in GWAS
&bull; To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
&bull; To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
&bull; Breast cancer in Chinese populations Xiao-ou Shu
&bull; Genetic association studies of skin cancer Jiali Han
&bull; Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
&bull; Genetic association studies of lung cancer in Chinese populations Daru Lu
&bull; Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
&bull; Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
&bull; Genetic association studies of hypertension in Chinese populations Jiang He
&bull; GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
&bull; Molecular epidemiology of diabetes in Chinese populations Weiping Jia
&bull; Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
&bull; Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
&bull; Genetic structure of Chinese population Li Jin
&bull; High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
&bull; Molecular genetics study of neural tube defect Hongyan Wang
&bull; Risk prediction using genetic variants in prostate cancer Jianfeng Xu
&bull; Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
&bull; Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时　　间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹，高歌 (Shanghai, China)；Tamara Adams (U.S.)
联系电话： 21-55664495 (Shanghai, China)；336-713-7532 (U.S.)
回执邮箱： GWAS2009@gmail.com (Shanghai, China)；tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)&bull; Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
&bull; Genetic epidemiology of skin cancer and breast cancer
&bull; Genome-wide association studies
&bull; Gene-environment interaction&bull; Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
&bull; Genetic epidemiology of hypertension
&bull; Gene-nutrition interaction of cardiovascular disease&bull; Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
&bull; Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
&bull; Genome-wide association studies
&bull; Genetic variants and association study&bull; Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
&bull; Molecular endocrinology and diabetes&bull; Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
&bull; Genetic and molecular epidemiology of lung cancer and glioma
&bull; Genetics of metabolism diseases
&bull; Genetic markers for population genetics&bull; Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
&bull; Genetic and molecular epidemiology of lung cancer and glioma
&bull; Genetics of metabolic disease&bull; Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
&bull; Genetic and lifestyle predictors of cancer and other chronic diseases
&bull; Cohort study methodology
&bull; Incorporating biomarkers in risk prediction&bull; Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
&bull; Translational cancer research
&bull; Gene expression profiling
&bull; Cancer genome high-throughput sequencing&bull; Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
&bull; Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)&bull; Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
&bull; Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
&bull; Genetic susceptibility to cancer
&bull; DNA repair and apoptosis phenotype markers&bull; Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
&bull; Genetic epidemiology of prostate cancer
&bull; Genome-wide association and fine mapping analysis
&bull; Risk prediction using genetic markers and other clinicopathologic variables&bull; Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
&bull; Molecular epidemiology of smoking-related cancers
&bull; Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
&bull; Gene-environmental interaction between genetic markers and environmental factors&bull; S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
&bull; High-throughput genotyping and sequencing
&bull; Genetic epidemiology of prostate cancer&bull; Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
&bull; molecular and genetics of complex diseases&bull; Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
&bull; Molecular and genetics of cardiovascular diseases&bull; Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
&bull; Topic of presentation: Molecular epidemiology of stomach cancer
&nbsp;

包：A 国内企业（3M×3M）12800元/个标准展位。境外企业（3M×3M）$3000美元/个标准展位。B 供希望...类别：钻石级赞助单位，独家总赞助/独家总冠名------赞助金额：48万人民币B、 白金级赞助机构：限一家，企业发展方向有海外市场，在行业内有良好口碑

后患者的的身体活动情况在术后能否得到提高却一直没有明确的研究。针对上述问题，澳大利亚的PaulaHardingD医生首次使用GT1M...后进行标准的物理治疗，包括术后1天在助行器及理疗师帮助下开始负重行走，并进行床上运动练习。使用GT1M加速器测量患者术前及术后6个月时的运动情况，并对患者疼痛、髋

。据研究人员估计，仅美国而言，只要适度减少一种主要污染物（废气和工业空气污染物中细颗粒物3.9μg/m3）就可以使每年...2013年为空气年。目前EU对细微颗粒物质的限制为不少于25μg/m3（每年平均值，高于WHO制定的10μg/m3）。然而，即便低于这个浓度，空气污染

Kenneth M.C. Cheung等在中国南方做了一项基础人群的横断面研究，研究共纳入2599名居民（其中男性1040名，女性1599名，平均年龄41.9岁）。参加者...有腰椎间盘变性。有腰椎间盘变性者的BMI比没有腰椎间盘变性者显著高（23.3 kg/m2 对21.7 kg/m2; P<0.001）。研究发现腰椎间盘变性随BMI

效，但是瑜伽课程和伸展课程相比并无明显效果上的区别。西雅图健康研究机构的Karen J. Sherman, Ph.D., M.P.H.和她的同事设计..., Chapel Hill的Timothy S. Carey, M.D., M.P.H.指出“Sherman等所做的研究是一项实际的比较效果的演技

挥了某些其他作用。于是，美国杜克大学医学中心和哥伦比亚大学联合开展了一项研究以揭示其中的原因。这项研究以体重指数(BMI)超过35 kg/m2的2型糖尿病... kg/m2的重度肥胖2型糖尿病患者的治疗选择之一，但是只有不到一半的糖尿病患者达到了如此高的超重标准。代表了全球200多家糖尿病团体的国际糖尿病联盟(IDF)最近也提出

最新流行病学数据显示，植入主动脉生物瓣膜的病人术后应接受六个月的华法林抗凝治疗。Charlotte Mérie（哥本哈根大学根措夫特医院...的临床试验，这方面的现有治疗指南一直很混乱。Mérie告诉heartwire：“我们带来的信息是惊人的，在考虑治疗指南时

企业标准展台￥8800元/9m2￥1200元/9m

德国的Marius M. Hoeper等研究人员对此展开研究，其结果发表于2013年3月12日的Circulation杂志上。&nbsp...202例患者，41%患者接受接受3种肺动脉高压药物治疗，其余使用2种药物治疗。24周后经安慰剂校正后的平均治疗效果（6分钟步行距离）为32m（95% CI

Kutlik（BA）和A.M. Barrett（MD）撰写的论文：左侧大脑损伤与高风险医院获得性感染相关。该发现可影响针对大脑中介免疫防御、感染控制以及卒中和创伤性...。“临床医生很少考虑大脑和免疫的关系”A.M.Barrett, MD说道，“但左侧和右侧大脑活动的平衡将会影响

约翰霍普金斯大学医学院的美国外科医师学会会员Timothy M. Pawlik博士等人进行了一项研究，研究人员对手术治疗早期肝细胞癌(HCC)的应用进行了定量...分析结果则表明，患者年龄、收入水平、肿瘤因素、肝脏相关并发症以及医院因素等为接受手术治疗的相关因素。Timothy M. Pawlik博士等人认为

重建方法；6. DIEP皮瓣乳房重建术；7. 乳房重建时机的探讨；8. 乳房重建的临床及基础研究；9. 手术... Robb M.D.: Chairman and Professor Department of Plastic Surgery The University

》（Nano）杂志7月刊上。这项技术由一种成像技术与一种造影剂结合而成。前者由生物医学工程系Gene K. Beare杰出教授Lihong Wang（汪立宏）开发，后者由James M. Mayer教授的研究小组的Younan Xia教授发明。这项技术可以产生令人震惊的、非常清晰的肿瘤三维图像。光声层析成像

2016 年备受大家欢迎的八个幻灯。